PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28791489-7	2017	RESULTS: Inhibition of ERK activation with selumetinib, a MEK1/2 inhibitor, blocked EGF-induced expansion of CD44+/CD24- populations.	AZD 6244	43-54	CD44 molecule (Indian blood group)	Homo sapiens	109-113	
26384399-9	2015	TNBC cells treated with selumetinib showed inhibition of anchorage-independent growth, an indicator of in vivo tumorigenicity (P < 0.005), and decreases in the CD44(+)CD24(-/low) fraction, ALDH1 activity, and mammosphere-forming efficiency.	AZD 6244	24-35	CD44 molecule (Indian blood group)	Homo sapiens	163-167